INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,773,000 | +9.2% | 268,000 | 0.0% | 2.12% | +0.1% |
| Q2 2022 | $5,285,000 | -16.1% | 268,000 | 0.0% | 2.12% | +0.3% |
| Q1 2022 | $6,298,000 | +13.7% | 268,000 | +31.8% | 2.11% | +38.0% |
| Q4 2021 | $5,539,000 | -1.1% | 203,354 | 0.0% | 1.53% | +3.9% |
| Q3 2021 | $5,600,000 | -3.2% | 203,354 | 0.0% | 1.47% | +9.5% |
| Q2 2021 | $5,787,000 | +54.1% | 203,354 | +84.4% | 1.34% | +28.8% |
| Q1 2021 | $3,755,000 | -24.2% | 110,254 | -25.9% | 1.04% | -43.6% |
| Q4 2020 | $4,952,000 | – | 148,743 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |